Novotech has engaged Citeline to support its clinical development programmes and help improve the rate at which sponsored clinical studies are planned and carried out.

Citeline, a leader in global pharmaceutical intelligence solutions, will provide its TrialTrove to monitor clinical trials as well as SiteTrove, which identifies and tracks clinical trial sites and investigators worldwide.

Citeline Asia Pacific commercial director Robert Roseberry said that costly delays in clinical study programmes can be avoided through access to accurate intelligence.

“TrialTrove monitors over 100,000 individual clinical trials worldwide and the SiteTrove service currently tracks the trial activities of over 190,000 clinical investigators,” Roseberry said.

Novotech is headquartered in Australia with a management-hub in Malaysia and manages trials in nine Asia Pacific countries, including India, Australia, South Korea and Taiwan.